• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, March 26

Serum Institute of India Ltd, India's largest vaccine manufacturer, on Monday announced the launch of indigenously developed HIB (Haemophilus influenzae type b) vaccine. The Serum Institute has a capacity to produce over 100 million doses of the vaccine. It will supply this new-age vaccine to GAVI (Global Alliance for Vaccines and Immunisation), PAHO (Pan American Health Organisation) and Unicef.

"Serum Institute is the only indigenous manufacturers of HIB vaccine in India today, unlike other vaccine manufacturers who import in bulk. HIB vaccine is fully manufactured in India. The institute has invested significantly in R&D and these efforts are yielding results," said Dr Cyrus Poonalwala, Chairman, Serum Institute of India.

More Stories on : New Products & Services | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Swipe Visa card at Andhra Bank to fly Kingfisher

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line